Afuco™ Anti-EGFL7 ADCC Recombinant Antibody (Parsatuzumab), ADCC Enhanced (CAT#: AFC-TAB-902)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFL7. Parsatuzumab is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Human
  • Derivation
  • Humanized (from mouse)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Clone
  • Parsatuzumab
  • Applications
  • ELISA, IP, FC, FuncS, Neut
  • Conjugate
  • Unconjugated
  • Generic Name
  • Parsatuzumab
  • Related Disease
  • Solid tumors

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Parsatuzumab; 1312797-14-0; RG7414; MEGF0444A; EGFL7; EGF-like-domain, multiple 7; epidermal growth factor-like protein 7; ZNEU1; EGF-like protein 7; NOTCH4-like protein; vascular endothelial statin; multiple EGF-like domains protein 7;

Related Resources

  • Biosimilar Overview
Please refer to Parsatuzumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Parsatuzumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Parsatuzumab"

Anti-Human EGFL7 Recombinant Antibody (Parsatuzumab)
Recombinant humanized (from mouse) antibody expressed in CHO binding to human EGFL7. Parsatuzumab is a humanized monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to EGFL7.

See other products for "EGFL7"

Single-domain Antibody

CAT Product Name Application Type
NAB-834-VHH Recombinant Anti-Human EGFL7 VHH Single Domain Antibody IHC, ICC, FC, FA, FUNC Llama VHH

Humanized Antibody

CAT Product Name Application Type
TAB-902 Anti-Human EGFL7 Recombinant Antibody (Parsatuzumab) Block IgG1 - kappa

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for AFC-TAB-902. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare